Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

The NanoRam™ is a state-of-the-art compact Raman handheld spectrometer and integrated computing system for material identification and verification within cGMP compliant facilities. Designed for use by non-specialists, the NanoRam is easy to use and operates single-handedly, weighing less than 2.2lbs. It allows rapid development of standardized and validated methods to facilitate inspection for purity and quality, making it the ideal choice for pharmaceutical, chemical, and material identification, whether in the lab, the warehouse, the loading dock or the field.  The NanoRam is the only handheld Raman device that features a temperature controlled detector, providing superior data quality and unprecedented system stability. Coupling this proprietary thermoelectric cooling with our patented CleanLaze® laser stabilization technology and high speed micro-processor, it provides laboratory performance in the palm of your hand. The first rate signal reduces the need for further testing, therefore decreasing production costs and escalating productivity, all at the same time.

www.nanoram.com

Featured whitepaper

A comparison of the attributes of the AccuGENX-ID microbial sequencing methods versus MicroSEQ v2.0
Author: Accugenix
Executive Summary: A detailed analysis of the differences between AccuGENX-ID™ and the MicroSEQ® v2.0* methodologies in obtaining an accurate identification are discussed.

Download the whitepaper >>

Other whitepapers available for download:

Autoantibody biomarker panels for improved disease diagnosis
Author: Oxford Gene Technology

Utilizing Colony-Forming Cell Assays In Toxicity Testing
Author: STEMCELL Technologies

An Interview with Dr. John Rossi
Author: Integrated DNA Technologies

RNA-Seq Data Comparison with Gene Expression Microarrays
Author: illumina

The importance of being profiled: Improving drug candidate safety and efficacy using cross-target profiling
Author: Merck Millipore

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- B&W Tek, Inc.
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- EMD Millipore - NEW
- Expo Technologies, LLC.
- GE Analytical Instruments
- HACH LANGE GMBH
- Merck Millipore - NEW
- Peter Huber Kältemaschinenbau
- Porvair Sciences Ltd
- Randox Pharma Services
- Rapid Micro Biosystems
- Realia
- Synbiosis
- Syngene

Add your company here

GSK confirms significant investments in UK manufacturing: Ulverston in Cumbria selected as site of new biopharmaceutical factory

GSK is to invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines. The company announced selection of Ulverston in Cumbria as the location for the first new GSK manufacturing facility to be built in the UK for almost 40 years.

Read the full story >>

  GlaxoSmithKline logo

More pharmaceutical & life science news

Biomarker specialist Activiomics appoints Dr Trevor Nicholls as Non-Executive Chairman
Dr Nicholls has over 30 years’ experience of building international businesses...

US court denies preliminary injunction application against the FDA
The US District Court for the District of Columbia issued an opinion and order in AstraZeneca’s lawsuit...

Sanofi and Regeneron report Phase 2 data for potential first-in-class lipid-lowering PCSK9 antibody
Data from two Phase 2 trials announced...

Teva announces FDA approval of QNASLTM
New treatment with “dry” mode of delivery seeks to address unmet needs of seasonal and perennial allergy sufferers...

Amgen’s PCSK9 Inhibitor reduced LDL cholesterol up to 81 percent in Phase 1b study
Robust AMG 145 Phase 2 program expected to deliver results in 2012...

In TRA-2P Study, adding Merck’s vorapaxar to standard of care significantly reduced the risk of cardiovascular events
Results from TRA-2P study - published...

GSK and Theravance announce completion of the Relovair™* registrational programme
COPD and asthma regulatory plans remain on track for submission from mid-2012...

BYETTA® approved for use with basal insulin in Europe
Patients in pivotal study achieved better glycemic control overall and after meals...

UK court finds SEROQUEL XR® formulation patent invalid
The High Court in the UK has rendered its opinion on the formulation patent protecting SEROQUEL XR®...

Lundbeck appoints new vice president of business development
Lundbeck has appointed Jacob Tolstrup as new vice president with responsibility for the company's business development...

Abbott selects AbbVie as new name for future research-based pharmaceutical company
AbbVie the new, independent research-based pharmaceutical company...

Featured supplier news

Event: Advances in Raman spectroscopy in pharmaceutical analysis
Thursday 17 May 2012, The Royal Society of Chemistry, London...

Interview with Susan Najjar, Marketing Director for Informatics at Thermo Fisher Scientific
Freddy White, EPR speaks to Susan Najjar at Thermo Fisher Scientific...

Switching to “simply paperless” particle counting from MET ONE saves you time immediately
Modern pharmaceutical injectable drug production is heavily regulated...

Syrris invites scientists to benefit from free flow and automated process chemistry workshops
Laboratory scale chemists offered educational workshops and seminars...

Heat Sealer reproducibly seals microplates of all types & sizes
The new MiniSeal Plus heat sealer from Porvair Sciences operates with a very high force...

Conferences, events & exhibitions:

Select Biosciences: AMT/LoaCEC/SCAE/AB&B
28 - 29 March 2012, Edinburgh, Scotland

Life Science User Group
29 March 2012, Massachusetts, USA

Life Science User Group
3 April 2012, California, USA

IPhEB 2012 2nd St. Petersburg International Pharmacy Engineering and Biotechnology Forum
3 - 5 April 2012, St. Petersburg, Russia

Development and Validation of Bioanalytical Assays for Biologics: Quantification (PK) and Immunogenicity Assays
12 - 13 April 2012, Dublin, Ireland

Analytical Method Validation for Biologics, Biopharmaceuticals and Other Therapeutic Products
23 - 24 April, Berlin, Germany

Pharma QbD Forum
24 - 25 April 2012, Berlin, Germany

LogiPharma Europe
24 - 26 April 2012, Geneva, Switzerland

QA/QC Strategy for Biopharmaceuticals and Biologics
25 - 27 April 2012, Berlin, Germany

Austropharm
26 - 28 April 2012, Vienna, Austria

RNAi & Single Cell Biology-2012 Summit
1 - 2 May 2012, Waltham, USA